Literature DB >> 143355

Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.

G M Taylor, S V Jones, J C Ridway, R Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 143355      PMCID： PMC1541101     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy.

Authors:  T P Klouda; S D Lawler; R L Powles; R T Oliver; C K Grant
Journal:  Transplantation       Date:  1975-03       Impact factor: 4.939

2.  Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; R Moelle; H Schaoua
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

3.  Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells.

Authors:  J M Zarling; P C Raich; M McKeough; F H Bach
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

4.  Resistance of certain leukaemic myeloblasts to immunological attack.

Authors:  I C MacLennan; D G Gale; J Wood
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

5.  T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction.

Authors:  T Han; B Dadey
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

6.  Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture.

Authors:  H P Lohrmann; L Novikovs; R G Graw
Journal:  Nature       Date:  1974-07-12       Impact factor: 49.962

7.  Human mixed lymphocyte culture using separated lymphocyte populations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

8.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

9.  Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.

Authors:  G M Taylor; R Harris; C B Freeman
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

10.  Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

Authors:  G M Taylor; C B Freeman; R Harris
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640
View more
  3 in total

1.  Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.

Authors:  G M Taylor; W D Fergusson; R Harris
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

2.  An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.

Authors:  G M Taylor; W Fergusson; P A Dyer; R Harris; G Morrell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.

Authors:  G M Taylor; J C Ridway; W D Fergusson; R Harris
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.